Keep Medicine Out of the US-China Tech War

As Washington and Beijing tussle for dominance in frontier technologies, there’s one area in which competition shouldn’t preclude collaboration: innovative medicines. Beijing’s latest five-year plan for the biotechnology sector details how the country wants to lead the field globally. Unusually for an industrial blueprint, it comes with numeric targets.